Drugs / [131I]ICF01012
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03784625 | Oct 2019 → Jan 2025 | melanoma | Centre Jean Perrin | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [131I]ICF01012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03784625 ↗ |
| Modality | Other / unclassified | “targeted radionuclide therapy” NCT03784625 ↗ |
| Route | Intravenous | “intravenous administration” NCT03784625 ↗ |